Amanda Collier

Amanda graduated with a First in Molecular Cell Biology from the University of York in 2014. During her degree, she undertook a research placement at the Regenerative Medicine Unit at Pfizer Neusentis, where she studied the role of Sox2 in neural stem cells and reprogramming. Funded by an MRC Studentship (, Amanda joined the Babraham Institute in 2014 to investigate the function and regulation of Polycomb-Group proteins in stem cell fate decisions.